image
Healthcare - Medical - Care Facilities - NYSE - US
$ 3.485
8.25 %
$ 1.44 B
Market Cap
-7.31
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one AGL stock under the worst case scenario is HIDDEN Compared to the current market price of 3.48 USD, agilon health, inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one AGL stock under the base case scenario is HIDDEN Compared to the current market price of 3.48 USD, agilon health, inc. is HIDDEN

This DCF valuation model was last updated on May, 7, 2025.

The intrinsic value of one AGL stock under the best case scenario is HIDDEN Compared to the current market price of 3.48 USD, agilon health, inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart AGL

image
$6.0$6.0$5.5$5.5$5.0$5.0$4.5$4.5$4.0$4.0$3.5$3.5$3.0$3.0$2.5$2.5$2.0$2.0$1.5$1.515 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '25
FINANCIALS
6.06 B REVENUE
40.41%
-292 M OPERATING INCOME
-25.85%
-260 M NET INCOME
1.03%
-57.8 M OPERATING CASH FLOW
63.01%
140 M INVESTING CASH FLOW
417.80%
-2.58 M FINANCING CASH FLOW
98.66%
1.52 B REVENUE
4.93%
-108 M OPERATING INCOME
19.03%
-106 M NET INCOME
16.60%
16.4 M OPERATING CASH FLOW
313.15%
23.7 M INVESTING CASH FLOW
-49.16%
-22 K FINANCING CASH FLOW
98.44%
Balance Sheet agilon health, inc.
image
Current Assets 1.46 B
Cash & Short-Term Investments 400 M
Receivables 1.02 B
Other Current Assets 40.8 M
Non-Current Assets 276 M
Long-Term Investments 61.8 M
PP&E 37 M
Other Non-Current Assets 178 M
23.07 %58.65 %3.56 %10.24 %Total Assets$1.7b
Current Liabilities 1.15 B
Accounts Payable 1.15 B
Short-Term Debt 0
Other Current Liabilities 0
Non-Current Liabilities 111 M
Long-Term Debt 41.5 M
Other Non-Current Liabilities 69.5 M
91.21 %3.29 %5.50 %Total Liabilities$1.3b
EFFICIENCY
Earnings Waterfall agilon health, inc.
image
Revenue 6.06 B
Cost Of Revenue 6.06 B
Gross Profit 4.84 M
Operating Expenses 297 M
Operating Income -292 M
Other Expenses -32 M
Net Income -260 M
7b7b6b6b5b5b4b4b3b3b2b2b1b1b00(1b)(1b)6b(6b)5m(297m)(292m)32m(260m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
0.08% GROSS MARGIN
0.08%
-4.82% OPERATING MARGIN
-4.82%
-4.29% NET MARGIN
-4.29%
-55.23% ROE
-55.23%
-15.00% ROA
-15.00%
-50.49% ROIC
-50.49%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis agilon health, inc.
image
00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)(100m)(100m)(120m)(120m)(140m)(140m)(160m)(160m)(180m)(180m)(200m)(200m)202020202021202120222022202320232024202420252025
Net Income -260 M
Depreciation & Amortization 24.5 M
Capital Expenditures -13.3 M
Stock-Based Compensation 50.7 M
Change in Working Capital 0
Others 127 M
Free Cash Flow -71 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets agilon health, inc.
image
Wall Street analysts predict an average 1-year price target for AGL of $4.4 , with forecasts ranging from a low of $2.5 to a high of $6.5 .
AGL Lowest Price Target Wall Street Target
2.5 USD -28.26%
AGL Average Price Target Wall Street Target
4.4 USD 26.26%
AGL Highest Price Target Wall Street Target
6.5 USD 86.51%
Price
Max Price Target
Min Price Target
Average Price Target
8877665544332211Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 14
6. Ownership
Insider Ownership agilon health, inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 3
0-3 MONTHS
248 K USD 4
3-6 MONTHS
67.2 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
agilon health, inc. (AGL) Q1 2025 Earnings Call Transcript agilon health, inc. (NYSE:AGL ) Q1 2025 Results Conference Call May 6, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steve Sell - Chief Executive Officer Jeff Schwaneke - Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Elizabeth Anderson - Evercore ISI Jailendra Singh - Truist Securities Justin Lake - Wolfe Research Amir Farahani - Bernstein Lisa Gill - JPMorgan Ryan Langston - TD Cowen Joanna Gajuk - Bank of America Ryan Daniels - William Blair Michael Ha - Baird Matthew Shea - Needham Daniel Grosslight - Citi Jenny Shen - BTIG George Hill - Deutsche Bank Whit Mayo - Leerink Partners Thomas Walsh - Barclays Operator Hello, everybody, and welcome to the agilon health First Quarter 2025 Earnings Conference Call. seekingalpha.com - 1 week ago
Agilon Health (AGL) Reports Break-Even Earnings for Q1 Agilon Health (AGL) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.01 per share a year ago. zacks.com - 1 week ago
Bloodied But Unbowed, Agilon Health Can Profit From Improving Market Dynamics agilon health's stock has surged over 165% YTD in 2025 despite a 77% decline since its 2021 IPO, driven by CMS rate hikes for 2026. The company faces challenges with significant operating losses and industry headwinds, but remains committed to value-based care over fee-for-service models. agilon's business model involves global capitation fees from health plan payors, focusing on Medicare Advantage through a network of physician partners. seekingalpha.com - 1 month ago
Agilon (AGL) Moves 26.1% Higher: Will This Strength Last? Agilon (AGL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road. zacks.com - 1 month ago
agilon health to Participate in BofA Securities 2025 Health Care Conference WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the BofA Securities 2025 Health Care Conference including a fireside chat presentation on Wednesday, May 14 at 1:00 PM Eastern Time. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the “Events & Presentations” section of agilon health's inve. businesswire.com - 1 month ago
agilon health Sets Date to Report First Quarter 2025 Financial Results WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2025 after the market closes on Tuesday, May 6, 2025, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international pa. businesswire.com - 1 month ago
Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year? Here is how Agilon Health (AGL) and Paragon 28, Inc. (FNA) have performed compared to their sector so far this year. zacks.com - 1 month ago
Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals J.P. Morgan analyst Lisa C. Gill, with a Neutral rating, updated estimates for Agilon Health, Inc. AGL following fourth-quarter results posted last month. benzinga.com - 2 months ago
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year? Here is how Agilon Health (AGL) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year. zacks.com - 2 months ago
agilon health, inc. (AGL) Q4 2024 Earnings Call Transcript agilon health, inc. (NYSE:AGL ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Justin Lake - Wolfe Research Jack Slevin - Jefferies Ryan Langston - TD Cowen Amir Farahani - Bernstein Jailendra Singh - Truist Securities Michael Ha - Baird Elizabeth Anderson - Evercore Adam Ron - Bank of America Ryan Daniels - William Blair Whit Mayo - Leerink Partners Daniel Grosslight - Citi David Larsen - BTIG George Hill - Deutsche Bank Matt Shea - Needham Operator Hello and welcome to the agilon health Fourth Quarter 2024 Earnings Conference. seekingalpha.com - 2 months ago
Agilon (AGL) Reports Q4 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com - 2 months ago
Agilon Health (AGL) Reports Q4 Loss, Tops Revenue Estimates Agilon Health (AGL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.41 per share a year ago. zacks.com - 2 months ago
8. Profile Summary

agilon health, inc. AGL

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 1.44 B
Dividend Yield 0.00%
Description agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
Contact 6210 East US Highway 290, Austin, TX, 78723 https://agilonhealth.com
IPO Date April 15, 2021
Employees 1076
Officers Mr. Benjamin Shaker Chief Markets Officer Mr. Timothy Gertsch Vice President, Controller & Chief Accounting Officer Ms. Denise Zamore Chief Legal Officer & Secretary Mr. Kenny Bellendir Markets Chief Financial Officer Mr. Bill Farry Chief of Technology Innovation Mr. Steven Jackson Sell President, Chief Executive Officer & Director Leland Thomas Senior Manager of Investor Relations Mr. Mat Varghese Chief People Officer Mr. Jeffrey Alan Schwaneke CPA Executive Vice President & Chief Financial Officer Mr. Girish Venkatachaliah Chief Technology Officer